We attributed the lack of influence of MetS on DR to the balance between insulin resistance and insulin secretory defects, but markers that can be used to evaluate insulin secretory ability, such as the insulinogenic index or C-peptide levels, were not measured in our study. This evidence concerns the gene INS and metabolic syndrome.